The Management Board of Eurex Deutschland took the following decisions with effect from 22 March 2021:
This circular contains all information on the introduction of the new product and the updated sections of the relevant Rules and Regulations of Eurex Deutschland.
Production start: 22 March 2021
2. Required action
No action is required for existing participating Members in trading of KOSPI products.
For Members wishing to newly participate, a Eurex Readiness Newsflash will be sent out soon detailing the requirements for trading Eurex Daily Futures on KOSPI 200 Futures.
A. Product overview
Please refer to Attachment 1 for the product.
B. Contract specifications and product parameters
For general product parameters, please find an overview in table format in Attachment 1.
For the detailed Contract Specifications, please see Attachment 2.
The full version of the updated Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland (Contract Specifications) will be published on the Eurex website www.eurex.com as of start of trading under:
C. Admission to the Eurex T7 Entry Services (TES)
The new products will be admitted to the Eurex T7 Entry Services (TES). Please refer to the Contract Specifications in Attachment 2 for the minimum block trade sizes on product level.
An overview of the Eurex T7 Entry Services available for the products as well as detailed information on single product basis with regard to availability, possibility of utilisation and minimum entry size for the various Eurex T7 Entry Services is available on the Eurex website under the link:
The Eurex Daily Futures on KOSPI 200 Futures (FBK2) will be available in the simulation environment as of 15 February 2021.
E. Risk parameters
As of start of trading, risk parameters of the new products will be published on the Eurex website under the link:
and on the Eurex Clearing website www.eurex.com/ec-en/ under the following link:
where you will also find an updated list with details regarding Prisma-eligible Eurex products.
F. Excessive System Usage Fee and Order to Trade Ratio
The Excessive System Usage Fee and the Order to Trade Ratio were determined in line with the existing Equity Index Derivatives. For further information, please refer to the Eurex website under the following links:
G. Mistrade parameters and position limits
Mistrade ranges and position limits for the new products will be published as of start of trading on the Eurex website under the links:
H. Transaction fees
The transaction fees listed in Attachment 1 will apply. For details, please refer to the current Price List of Eurex Clearing AG, available on the Eurex website under the following link:
I. Vendor codes
At start of trading, vendor codes for the new products will be published on the Eurex website under the link:
J. Liquidity Provisioning
Please refer to Attachment 3 for the details regarding Liquidity Provisioning.
All Trading Participants of Eurex Deutschland and Vendors
Front Office/Trading, IT/System Administration, Auditing/Security Coordination
Market Status ⓘ
The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.
Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message.
We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.
An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.